Quantbot Technologies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,400
Closed -$78K 1766
2022
Q2
$78K Buy
1,400
+700
+100% +$41.5K 0.01% 1204
2022
Q1
$43K Sell
700
-6,765
-91% -$414K ﹤0.01% 1230
2021
Q4
$411K Buy
7,465
+1,752
+31% +$91.4K 0.03% 581
2021
Q3
$300K Buy
+5,713
New +$339K 0.02% 721
2021
Q2
Sell
-2,300
Closed -$177K 1590
2021
Q1
$177K Buy
2,300
+1,900
+475% +$175K 0.02% 746
2020
Q4
$39K Sell
400
-100
-20% -$12.2K ﹤0.01% 900
2020
Q3
$70K Buy
+500
New +$83.4K 0.01% 797
2018
Q4
Sell
-820
Closed -$92K 1159
2018
Q3
$92K Sell
820
-743
-48% -$78.5K 0.01% 900
2018
Q2
$144K Buy
1,563
+418
+37% +$40.6K 0.01% 802
2018
Q1
$114K Buy
1,145
+379
+49% +$40.9K 0.01% 815
2017
Q4
$71K Buy
766
+618
+418% +$58.5K 0.01% 914
2017
Q3
$15K Buy
+148
New +$12.9K ﹤0.01% 1072
2017
Q1
Sell
-797
Closed -$51K 1235
2016
Q4
$51K Buy
+797
New +$49K 0.01% 832

Other funds holding LKFT

Quantbot Technologies's LKFT Position: Q3 2022 in Review

Quantbot Technologies sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2022, closing a stake of 1,400 shares — an estimated $78K sold.

Quantbot Technologies first reported a position in LKFT in Q4 2016 and held it in 13 quarters. The position peaked at $411K in Q4 2021. 84 funds tracked by Wall St. Rank hold LKFT as of Q3 2022.

  • Quantbot Technologies reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Quantbot Technologies sold 1,400 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2022, an estimated $78K.
  • Quantbot Technologies first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and held it in 13 quarters.
  • Quantbot Technologies's Lakefront Biotherapeutics American Depositary Shares position peaked at $411K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2022.

Based on Quantbot Technologies's 13F filing for Q3 2022, filed 7 Nov 2022.